Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C

BACKGROUND AND AIM: The accuracy for predicting virological outcomes of peginterferon-α and ribavirin therapy in patients with chronic hepatitis C is limited to approximately 80%, even with IL28B genotyping. Our in vitro study revealed that the numbers of (TA) dinucleotide repeats [(TA)n] of rs72258...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaki, Naohiko, Sugiyama, Masaya, Shimada, Noritomo, Tanaka, Yasuhito, Nakamuta, Makoto, Izumi, Namiki, Watanabe, Sumio, Tsubota, Akihito, Komatsu, Masafumi, Masaki, Tsutomu, Enomoto, Nobuyuki, Yoneda, Masashi, Murata, Kazumoto, Ito, Kiyoaki, Koike, Kazuhiko, Mizokami, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Clinical Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263356/
https://www.ncbi.nlm.nih.gov/pubmed/24910341
http://dx.doi.org/10.1111/jgh.12646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263356/
https://www.ncbi.nlm.nih.gov/pubmed/24910341
http://dx.doi.org/10.1111/jgh.12646

Ejemplares similares